Literature DB >> 11260397

Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.

J Wada1, H Zhang, Y Tsuchiyama, K Hiragushi, K Hida, K Shikata, Y S Kanwar, H Makino.   

Abstract

BACKGROUND: To elucidate the molecular mechanism of diabetic nephropathy, a high-density DNA filter array was employed to survey the gene expression profile of streptozotocin-induced diabetic CD-1 (ICR) mouse kidneys.
METHODS: Ten-week-old CD-1 male mice were divided into four groups: (1) control, (2) unilaterally nephrectomized (UX) mice, (3) streptozotocin (STZ)-induced diabetic (STZ) mice, and (4) STZ mice with unilateral renal ablation (STZ-UX). Pathological changes were examined at 24 weeks after the induction. The gene expression profile was compared between the control and STZ mice by a Gene Discovery Array (GDA).
RESULTS: The glomeruli in UX mouse kidney showed prominent glomerular hypertrophy, while the accumulation of mesangial matrix was minimal. Both STZ and STZ + UX mice had significant glomerular hypertrophy and glomerulosclerosis, and the lesions were not enhanced by renal ablation. By comparison between control and STZ mice, 16 clones that increased in expression with the induction of diabetes and 65 clones that decreased in diabetic kidneys were identified. The 37 known genes were related to glucose and lipid metabolism, ion transport, transcription factors, signaling molecules, and extracellular matrix-related molecules. The genes known to be involved in cell differentiation and organogenesis in various tissues (that is, Unc-18 homolog, POU domain transcription factor 2, lunatic fringe gene homolog, fibrous sheath component 1, Sox-17, fibulin 2, and MRJ) were found to be differentially expressed in the early phase of diabetic kidneys.
CONCLUSIONS: Hyperglycemia is a major determinant of glomerulosclerosis in STZ-induced diabetic CD-1 mice, and the altered gene expression in the early phase of diabetic kidney may be critical for the development of diabetic nephropathy.

Entities:  

Mesh:

Year:  2001        PMID: 11260397     DOI: 10.1046/j.1523-1755.2001.0590041363.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

Review 1.  Fibulins: physiological and disease perspectives.

Authors:  W Scott Argraves; Lisa M Greene; Marion A Cooley; William M Gallagher
Journal:  EMBO Rep       Date:  2003-12       Impact factor: 8.807

Review 2.  Glycemic memories and the epigenetic component of diabetic nephropathy.

Authors:  Samuel T Keating; Assam El-Osta
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

3.  Discovery of genes related to diabetic nephropathy in various animal models by current techniques.

Authors:  Jun Wada; Lin Sun; Yashpal S Kanwar
Journal:  Contrib Nephrol       Date:  2011-01-20       Impact factor: 1.580

Review 4.  Defining the genetic blueprint of kidney development.

Authors:  S Steven Potter; Eric W Brunskill; Larry T Patterson
Journal:  Pediatr Nephrol       Date:  2011-02-19       Impact factor: 3.714

5.  Gene expression programs of mouse endothelial cells in kidney development and disease.

Authors:  Eric W Brunskill; S Steven Potter
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

6.  Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice.

Authors:  Vijay K Yechoor; Mary-Elizabeth Patti; Robert Saccone; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

7.  Large-scale identification of genes implicated in kidney glomerulus development and function.

Authors:  Minoru Takemoto; Liqun He; Jenny Norlin; Jaakko Patrakka; Zhijie Xiao; Tatiana Petrova; Cecilia Bondjers; Julia Asp; Elisabet Wallgard; Ying Sun; Tore Samuelsson; Petter Mostad; Samuel Lundin; Naoyuki Miura; Yoshikazu Sado; Kari Alitalo; Susan E Quaggin; Karl Tryggvason; Christer Betsholtz
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

8.  TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes.

Authors:  Sandhya Xavier; Thiruvur Niranjan; Stefanie Krick; Taoran Zhang; Wenjun Ju; Andrey S Shaw; Mario Schiffer; Erwin P Böttinger
Journal:  J Am Soc Nephrol       Date:  2009-08-13       Impact factor: 10.121

Review 9.  Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models.

Authors:  Sylvana M L de Mik; Martin J Hoogduijn; Ron W de Bruin; Frank J M F Dor
Journal:  BMC Nephrol       Date:  2013-04-01       Impact factor: 2.388

10.  Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus.

Authors:  Yaomin Hu; Pamela J Kaisaki; Karène Argoud; Steven P Wilder; Karin J Wallace; Peng Y Woon; Christine Blancher; Lise Tarnow; Per-Henrik Groop; Samy Hadjadj; Michel Marre; Hans-Henrik Parving; Martin Farrall; Roger D Cox; Mark Lathrop; Nathalie Vionnet; Marie-Thérèse Bihoreau; Dominique Gauguier
Journal:  BMC Med Genomics       Date:  2009-07-09       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.